Mehta RM, Bansal S, Bysani S, Kalpakam H, et al. A shorter symptom-onset to remdesivir treatment (SORT) interval is associated with a lower mortality in moderate-to-severe COVID-19: a real-world analysis. Int J Infect Dis 2021 Feb 26. pii: S1201-9712(21)00178.
PMID: 33647517